Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "BHLH Transcription Factors" patented technology

BHLH transcription factors are often important in development or cell activity. BMAL1-Clock is a core transcription complex in the molecular circadian clock. Other genes, like c-Myc and HIF-1, have been linked to cancer due to their effects on cell growth and metabolism.

Transcription factors participating in regulating and controlling synthesis of bitter principles of cucumis melo and application of transcription factors

The invention provides transcription factors participating in regulating and controlling synthesis of bitter principles of cucumis melo and application of the transcription factors. A comparative genomics method is utilized for the first time, and the two bHLH transcription factors CmBr and CmBt for controlling synthesis of bitter taste are discovered in genomes of the cucumis melo, and separatelycontrol formation of the bitter taste in roots and wild fruits. Through a yeast one-hybrid technology, a gel retardation test and a tobacco transient expression system, it is proved that the two transcription factors can be directly combined with a promoter region of a bitter principle synthesis gene, and then the expression of the synthesis gene is activated; meanwhile, through transient expression of cotyledons of the cucumis melo, it is proved genetically that the overexpression of CmBr and CmBt can activate the expression of the bitter taste synthesis gene, so that the cotyledons withoutthe bitter taste obtain the phenotype of the bitter taste. The CmBt gene is located in a domestication region. The invention further discloses a molecular mechanism for formation of the bitter taste of the cucumis melo, and a theoretical basis is provided for breeding of the cucumis melo without the bitter taste.
Owner:INST OF VEGETABLE & FLOWERS CHINESE ACAD OF AGRI SCI

Transcription factor participating into regulation of muskmelon bitter principle synthesis and application of transcription factor

ActiveCN106749572ACo-domesticationPlant peptidesFermentationYeastNicotiana tabacum
The invention provides a transcription factor participating into regulation of muskmelon bitter principle synthesis and application of the transcription factor. A comparative genomics method is firstly utilized for finding two bHLH transcription factors CmBr and CmBt which control bitter synthesis in a muskmelon genome, the two bHLH transcription factors are respectively used for controlling the bitter formation at the root part and in the wild fruit. A yeast one-hybrid technology, a gel retardant experiment and a tobacco transient expression system are used for proving that the two transcription factors can be directly combined to a promoter region of a bitter principle synthesis gene, and can activate the expression of the synthesis gene; the muskmelon cotyledon transient expression proves that the overexpression of each of the CmBr and the CmBt can activate the expression of the bitter synthesis gene from the genetics, so that the bitter-free cotyledon can acquire the bitter phenotype. The CmBt gene is located in a domestication region. The invention further discloses a molecule mechanism of the muskmelon bitter formation, and provides the theoretical basis for the breeding of the bitter-free muskmelon.
Owner:INST OF VEGETABLE & FLOWERS CHINESE ACAD OF AGRI SCI

Transcription factor participating in regulating watermelon bitter principle and application thereof

ActiveCN106518994ATranslation terminated earlyMicrobiological testing/measurementPlant peptidesYeastGene Position
The invention provides a transcription factor participating in regulating watermelon bitter principle and an application thereof. Two bHLH transcription factors ClBr and ClBt controlling bitterness synthesis are discovered in watermelon genome for the first time by use of comparative genomics, wherein the two bHLH transcription factors control the formation of bitterness in the root and wild fruits respectively. The yeast one-hybrid technology, gel retardation experiment and tobacco transient expression system prove that the two transcription factors can be directly combined to the promoter area of the bitter principle synthesis gene and activate the expression of the synthesis gene; and meanwhile, through the transient expression of watermelon cotyledon, the overexpression of ClBr and ClBt is genetically proven to activate the expression of the bitterness synthesis gene so that the bitterless cotyledon obtains a bitterness phenotype. The ClBt gene encodes the mutation of an SNP so that the bitter fruit loses bitterness; and moreover, the gene positioned in an acclimation area is an acclimation gene. The invention further discloses a molecular mechanism forming watermelon bitterness and provides a theoretical basis for bitterless watermelon breeding.
Owner:INST OF VEGETABLE & FLOWERS CHINESE ACAD OF AGRI SCI

SmbHLH92 gene cloning primer, expression vector, function of regulating salvianolic acid biosynthesis and application

The invention discloses an encoding gene sequence of a Salvia miltiorrhiza Bunge bHLH transcription factor SmbHLH92 for regulating and controlling salvianolic acid synthesis. The gene SmbHLH92 provided by the invention has a nucleotide sequence as shown in SEQ ID No.1, and protein encoded by the gene has an amino acid sequence as shown in SEQ ID No.2. A subcellular localization experiment shows that the SmbHLH92 is localized in a cell nucleus. An SmbHLH92-RNAi vector is constructed, Salvia miltiorrhiza Bunge is subjected to genetic transformation, transgenic hairy roots are obtained, and compared with a reference strain (a strain obtained by transforming an RNAi empty vector), the SmbHLH92-RNAi strain has the advantage that the content of four phenolic acid components in the SmbHLH92-RNAistrain is remarkably increased. A real-time fluorescent quantitative PCR result shows that the expression quantity of a key enzyme gene in a salvianolic acid pathway is remarkably increased in the SmbHLH92-RNAi strain. The SmbHLH92 provided by the invention has a function of negatively regulating and controlling the biosynthesis of salvianolic acid compounds, and the compounds show outstanding curative effects in the aspect of treating cardiovascular and cerebrovascular diseases. The invention provides a new research thought for increasing the content of the salvianolic acid compounds by utilizing genetic engineering, and provides a target gene for developing excellent variety breeding of the Salvia miltiorrhiza Bunge.
Owner:INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products